We are grateful for external funding from The Research Council of Norway, Norwegian Cancer Society, South-Eastern Norway Regional Health Authority and EU.
Gopalakrishnan RP, Østrøm MS, Skjeldal FM, Bakke O, Bogen B, Huszthy PC(2024) B Cells With Complementary B Cell Receptors Can Kill Each Other Eur J Immunol, 55(1), e202350890 DOI 10.1002/eji.202350890, PubMed 39520365
Garcia I, Bråte J, Fossum E, Rohringer A, Moen LV, Hungnes O, Fjære O, Zaragkoulias K, Bragstad K(2024) Recombinant SARS-CoV-2 Delta/Omicron BA.5 emerging in an immunocompromised long-term infected COVID-19 patient Sci Rep, 14(1), 25790 DOI 10.1038/s41598-024-75241-3, PubMed 39468221
Tunheim G, Fossum E, Robertson AH, Rø GØI, Chopra A, Vaage JT, Vikse EL, Kran AB, Magnus P, Trogstad L, Mjaaland S, Hungnes O, Lund-Johansen F(2024) Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults BMC Infect Dis, 24(1), 841 DOI 10.1186/s12879-024-09670-w, PubMed 39164637
